Compare, Analyse Torrent Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ACTAVIS (US) - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ACTAVIS
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-19
ACTAVIS
Dec-18
TORRENT PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,96413,783-   
Low Rs1,2459,246-   
Sales per share (Unadj.) Rs453.43,381.0-  
Earnings per share (Unadj.) Rs25.8-1,089.0-  
Cash flow per share (Unadj.) Rs62.3356.3-  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs279.213,944.9-  
Shares outstanding (eoy) m169.22332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.53.4 103.9%   
Avg P/E ratio x62.2-10.6 -588.6%  
P/CF ratio (eoy) x25.832.3 79.7%  
Price / Book Value ratio x5.70.8 696.0%  
Dividend payout %65.90-   
Avg Mkt Cap Rs m271,5133,829,666 7.1%   
No. of employees `00013.616.9 80.5%   
Total wages/salary Rs m14,0380-   
Avg. sales/employee Rs Th5,642.666,538.9 8.5%   
Avg. wages/employee Rs Th1,032.40-   
Avg. net profit/employee Rs Th320.9-21,432.2 -1.5%   
INCOME DATA
Net Sales Rs m76,7281,124,508 6.8%  
Other income Rs m57121,504 2.7%   
Total revenues Rs m77,2991,146,012 6.7%   
Gross profit Rs m19,83129,468 67.3%  
Depreciation Rs m6,177480,703 1.3%   
Interest Rs m5,03864,891 7.8%   
Profit before tax Rs m9,187-494,621 -1.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,570126,148 -2.8%   
Tax Rs m1,254-6,268 -20.0%   
Profit after tax Rs m4,363-362,205 -1.2%  
Gross profit margin %25.82.6 986.3%  
Effective tax rate %13.61.3 1,076.7%   
Net profit margin %5.7-32.2 -17.7%  
BALANCE SHEET DATA
Current assets Rs m50,375461,214 10.9%   
Current liabilities Rs m51,653408,005 12.7%   
Net working cap to sales %-1.74.7 -35.2%  
Current ratio x1.01.1 86.3%  
Inventory Days Days9220 470.1%  
Debtors Days Days6866 103.0%  
Net fixed assets Rs m83,648127,288 65.7%   
Share capital Rs m8460-   
"Free" reserves Rs m46,3970-   
Net worth Rs m47,2444,638,070 1.0%   
Long term debt Rs m39,1291,633,233 2.4%   
Total assets Rs m141,2097,250,359 1.9%  
Interest coverage x2.8-6.6 -42.6%   
Debt to equity ratio x0.80.4 235.2%  
Sales to assets ratio x0.50.2 350.3%   
Return on assets %6.7-4.1 -162.3%  
Return on equity %9.2-7.8 -118.3%  
Return on capital %12.3-4.8 -254.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m16,5810-   
CASH FLOW
From Operations Rs m17,981401,744 4.5%  
From Investments Rs m-2,413220,706 -1.1%  
From Financial Activity Rs m-13,145-689,514 1.9%  
Net Cashflow Rs m2,380-66,728 -3.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.23 Rs / USD

Compare TORRENT PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: NATCO PHARMA  GSK PHARMA  DISHMAN PHARMA  ABBOTT INDIA  DR. REDDYS LAB  



Today's Market

Sensex Ends 231 Points Higher; Capital Goods and FMCG Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended their trading session on a positive note. At the closing bell, the BSE Sensex stood higher by 231 points (up 0.6%).

Related Views On News

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Buy the Best Safe Stocks in 2020 (The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market (Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

The Best Asset Class to Invest in 2020 (Fast Profits Daily)

Jan 24, 2020

Why I'm most bullish on this asset class above all else in 2020.

Small is Beautiful in 2020 (A Prediction You Don't Want to Miss) (Profit Hunter)

Jan 17, 2020

As always Apurva will predict the best asset class to invest in in the coming year, last year he predicted gold and he was bang on! And this year he predicts... wait, you have to read to find out! Don't miss this.

The Smallcap Rebound Has Begun (13 Stocks Up Over 20% in the last Month) (Profit Hunter)

Jan 21, 2020

The best smallcap stocks to bet on to get rich in this market rebound.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
A Simple Test to Find out If a Stock Has 100x Potential
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

TORRENT PHARMA SHARE PRICE


Jan 29, 2020 03:37 PM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - FULFORD INDIA COMPARISON

COMPARE TORRENT PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS